核糖霉素，作为新霉素生物合成中的一种中间体。
Ribostamycin, as an intermediate in the biosynthesis of neomycin.
作者信息
Baud H, Betencourt A, Peyre M, Penasse L
出版信息
J Antibiot (Tokyo). 1977 Sep;30(9):720-3. doi: 10.7164/antibiotics.30.720.
PMID:924894
Abstract
A mutant of a neomycin-producting Streptomyces fradiae was found which synthesizes ribostamycin instead of neomycin. After a reverse mutation new colonies were obtained producting neomycin again. Ribostamycin might thus be considered as an intermediate in the biosynthesis of neomycin.
摘要
发现一种生产新霉素的弗氏链霉菌突变体，它合成核糖霉素而非新霉素。经过回复突变后，再次获得了产生新霉素的新菌落。因此，核糖霉素可被视为新霉素生物合成的中间体。
Zotero 插件